BACKGROUND: Human T cell lymphotropic virus type 1 (HTLV-1) infection has been associated with recurrent and disseminated strongyloidiasis and adult T cell leukemia/lymphoma (ATLL). METHODS: We compared immunological aspects and markers for ATLL in HTLV-1 patients with or without strongyloidiasis, and evaluated the influence of Strongyloides stercoralis treatment on the immune response and clinical outcomes of HTLV-1 infection. RESULTS: Levels of TNFα and IFNγ were lower in patients coinfected with HTLV-1 and S. stercoralis than in patients with HTLV-1 only (p < 0.05), and there was an increase in TNFα levels after anthelmintic treatment. Levels of sIL-2R were higher in patients with HTLV-1 coinfected with S. stercoralis and anthelmintic treatment decreased sIL-2R levels (p < 0.05). The one patient who developed ATLL was coinfected with S. stercoralis. CONCLUSION: These data show that helminthic infection has a modulatory role in HTLV-1 infection and that S. stercoralis may be a cofactor in the development of ATLL.
BACKGROUND:Human T cell lymphotropic virus type 1 (HTLV-1) infection has been associated with recurrent and disseminated strongyloidiasis and adult T cell leukemia/lymphoma (ATLL). METHODS: We compared immunological aspects and markers for ATLL in HTLV-1patients with or without strongyloidiasis, and evaluated the influence of Strongyloides stercoralis treatment on the immune response and clinical outcomes of HTLV-1 infection. RESULTS: Levels of TNFα and IFNγ were lower in patients coinfected with HTLV-1 and S. stercoralis than in patients with HTLV-1 only (p < 0.05), and there was an increase in TNFα levels after anthelmintic treatment. Levels of sIL-2R were higher in patients with HTLV-1 coinfected with S. stercoralis and anthelmintic treatment decreased sIL-2R levels (p < 0.05). The one patient who developed ATLL was coinfected with S. stercoralis. CONCLUSION: These data show that helminthic infection has a modulatory role in HTLV-1 infection and that S. stercoralis may be a cofactor in the development of ATLL.
Authors: K Nakada; K Yamaguchi; S Furugen; T Nakasone; K Nakasone; Y Oshiro; M Kohakura; Y Hinuma; M Seiki; M Yoshida Journal: Int J Cancer Date: 1987-08-15 Impact factor: 7.396
Authors: Paulo Oliveira; Néviton M Castro; André L Muniz; Davi Tanajura; Julio C Brandão; Aurélia F Porto; Edgar M Carvalho Journal: Urology Date: 2010-02-26 Impact factor: 2.649
Authors: A F Porto; F A Neva; H Bittencourt; W Lisboa; R Thompson; L Alcântara; E M Carvalho Journal: Parasite Immunol Date: 2001-09 Impact factor: 2.280
Authors: Marina F Caskey; Daniel J Morgan; Aurelia F Porto; Silvana P Giozza; Andre L Muniz; Glória O Orge; Maria J Travassos; Yolanda Barrón; Edgar M Carvalho; Marshall J Glesby Journal: AIDS Res Hum Retroviruses Date: 2007-03 Impact factor: 2.205
Authors: Olga Quintero; Carolina A Berini; Carlos Waldbaum; Alejandra Avagnina; María Juarez; Silvia Repetto; Juan Sorda; Mirna Biglione Journal: Front Microbiol Date: 2017-12-06 Impact factor: 5.640
Authors: Lauren E Springer; John B Patton; Tingting Zhan; Arnold B Rabson; Hsin-Ching Lin; Tim Manser; James B Lok; Jessica A Hess; David Abraham Journal: PLoS Negl Trop Dis Date: 2021-07-27